Author Archives for Fluidda webmaster

Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA) – a phase 2a randomized placebo-controlled trial

May 28, 2018 12:45 pm Published by Comments Off on Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA) – a phase 2a randomized placebo-controlled trial

Maher et al.
www.thelancet.com/respiratory Published online May 20, 2018